Acute respiratory distress syndrome and COVID-19: A literature review

M Hussain, S Khurram Syed, M Fatima… - Journal of …, 2021‏ - Taylor & Francis
Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …

Corticosteroids in COVID-19: pros and cons

A Bahsoun, Y Fakih, R Zareef, F Bitar, M Arabi - Frontiers in medicine, 2023‏ - frontiersin.org
The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Use of steroids in COVID-19 patients: A meta-analysis

M Thakur, AK Datusalia, A Kumar - European Journal of Pharmacology, 2022‏ - Elsevier
Background Emerging reports have shown the benefits of steroids in hospitalized COVID-19
patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …

The efficacy of oral/intravenous corticosteroid use in COVID-19 patients: a systematic review

IR Latarissa, F Rendrayani, GN Iftinan… - Journal of …, 2024‏ - Taylor & Francis
The COVID-19 pandemic is prompting extensive investigation into potential treatments,
including the use of corticosteroids to manage inflammation and mitigate severe disease …

Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the …

S Herrera, JM Aguado, FJ Candel, E Cordero… - Transplantation …, 2023‏ - Elsevier
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Corticosteroids use for COVID-19: An overview of systematic reviews

M Cruciani, I Pati, F Masiello, S Pupella… - Le Infezioni in …, 2022‏ - pmc.ncbi.nlm.nih.gov
Purpose A reappraisal of the validity of the conclusions of systematic reviews (SRs) and
meta-analyses related to corticosteroids use for the treatment of COVID-19. Material and …

Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs

X Ye, Y Li, F Luo, Z Xu, K Kasimu, J Wang, P Xu… - Clinical and …, 2024‏ - Springer
In the realm of acute respiratory infections, coronavirus disease-19 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a global public …

Efficacy and safety of immunomodulators in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials

T Ngamprasertchai, R Kajeekul, C Sivakorn… - Infectious Diseases and …, 2022‏ - Springer
Introduction Many immunomodulators have been studied in clinical trials for the treatment of
coronavirus disease 2019 (COVID-19). However, data identifying the most effective and …

Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort …

G Moreno, R Carbonell, I Martin-Loeches… - Annals of Intensive …, 2021‏ - Springer
Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients–the BISHOP study

GG Resende, R da Cruz Lage, SQ Lobê… - Infectious …, 2022‏ - Taylor & Francis
Background Patients with severe COVID-19 seem to evolve with a compromised antiviral
response and hyperinflammation. Neutrophils are critical players in COVID-19. IL-17A plays …